Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|December 12, 2024
Assessing the feasibility of handheld scanning technologies in neonatal intensive care: Trueness, acceptability, and suitability for personalised medical devicesDeanne August, Isabel Byram, David Forrestal, et al.
Clinical Trials (London, England)|June 17, 2023
Use of comprehensive recruitment strategies in the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE) multi-center clinical trialAndrea L Cherrington, Heidi Krause-Steinrauf, Vanita Aroda, et al.
International Wound Journal|August 19, 2025
Measurement and Sequelae of Neonatal Skin Injuries: A Prospective Diagnostic/Feasibility StudyDeanne August, Stephanie Hall, Nicole Marsh, et al.
JAMA Pediatrics|July 15, 2024
Securement to Prevent Noncuffed Central Venous Catheter Dislodgement in Pediatrics: The SECURED Superiority Randomized Clinical TrialTricia M Kleidon, Jessica Schults, Victoria Gibson, et al.
Diabetes, Obesity & Metabolism|August 15, 2023
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trialNatalia McInnes, Stephanie Hall, Heather A Lochnan, et al.
Diabetes Care|April 2, 2026
Comparison of the Continuous Glucose Monitoring Profiles of Four Glucose-Lowering Medications in the GRADE Randomized TrialRichard M Bergenstal, Jill P Crandall, Samuel P Rosin, et al.
The Journal of Infectious Diseases|September 20, 2005
Molecular epidemiology of foodborne hepatitis a outbreaks in the United States, 2003Joseph J Amon, Rose Devasia, Guoliang Xia, et al.
Cardiovascular Diabetology|November 26, 2020
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysisGilles R Dagenais, Lars Rydén, Lawrence A Leiter, et al.
The Journal of Clinical Endocrinology and Metabolism|April 21, 2022
Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND TrialTali Cukierman-Yaffe, Hertzel C Gerstein, Jan Basile, et al.
The Lancet. Neurology|June 21, 2020
Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trialTali Cukierman-Yaffe, Hertzel C Gerstein, Helen M Colhoun, et al.
Pageof 6